Introduction
The dimeric transcription factor activator protein 1 (AP-1) consists of members of the Jun (c-Jun, JunB, JunD), Fos (c-Fos, FosB, Fra-1, Fra-2), ATF and MAF protein families. AP-1 genes have been implicated in the pathogenesis of cancer in various tissues by regulating genes involved in tumor cell proliferation, survival, differentiation, invasiveness or angiogenesis (Eferl and Wagner, 2003) . However, the functions of AP-1 in intestinal tumorigenesis are not well understood. Increased expression of c-Jun, JunB and Fra-1 has been reported in human colorectal carcinoma (CRC) (Wang et al., 2000 (Wang et al., , 2002 , which may be regulated by the transcription factor complex b-catenin/TCF (Mann et al., 1999) . Loss of the tumor suppressor adenomatosis polyposis coli (APC) and subsequent activation of b-catenin/TCF is an early event in the molecular pathogenesis of sporadic and hereditary CRC (Kinzler and Vogelstein, 1996; Radtke and Clevers, 2005) . In the APC Min mouse model of intestinal tumorigenesis, c-Jun and in particular phosphorylated c-Jun are required for b-catenin-dependent tumor cell proliferation (Nateri et al., 2005) , suggesting that c-Jun/AP-1 is an important effector of b-catenin signaling.
Chronic inflammation such as inflammatory bowel disease predisposes to intestinal tumorigenesis and antiinflammatory agents have proven effective to prevent CRC (Janne and Mayer, 2000) . Although some candidates such as nuclear factor-kB or interleukin-6 have been identified (Becker et al., 2004; Greten et al., 2004) , there is still considerable need to better analyse the molecular links between inflammation and cancer. AP-1 is commonly activated in response to inflammatory stimuli and has been implicated in cytokine expression and cellular immune responses (Meixner et al., 2004; Wagner and Eferl, 2005; Hasselblatt et al., 2007) . Moreover, c-Jun/AP-1 has been implicated in human inflammatory bowel disease (Bantel et al., 2002) , suggesting that expression of AP-1 in intestinal and inflammatory cells might be an important mediator of inflammation-associated cancer and a promising target for future therapeutic approaches. In this study, we examined the functions of c-Jun during b-catenindependent cell proliferation and investigated the functions of c-Jun and other AP-1 proteins, such as JunB, JunD, c-Fos, Fra-1 and Fra-2 in colitis-associated cancer (CAC).
Results

Generation of mice lacking c-jun in intestinal epithelium
To generate mice specifically lacking c-jun in intestinal epithelium, mice with conditional alleles for c-jun were crossed with transgenic mice expressing Cre recombinase under the control of the Villin (Vil) promoter. Vil-Cre induced almost complete recombination in the small intestine and the deletion efficiency in proximal and distal colon was approximately 90% (Figure 1a ). c-Jun was predominantly expressed by differentiated cells of the small intestinal villous tips rather than within the proliferative crypt compartment (Figure 1b, black arrows) . In the colon, c-Jun was expressed in surface epithelium and to a lesser extent in crypt epithelial cells (Figure 1b , black arrows and arrowheads, respectively). c-Jun expression was absent in intestinal epithelium upon Vil-Cre-mediated recombination (c-jun , Figure 1b and data not shown). Importantly, c-jun
Dint and c-jun Dint* mice did not show any overt phenotype under resting conditions.
Functions of c-Jun upon activation of b-catenin in the small intestine The primary molecular events leading to adenoma initiation can be analysed directly using conditional models of b-catenin activation. c-jun Dint* mice were crossed with mice harboring one conditional allele of exon 3 of b-catenin (exon3 f/ þ ) (Harada et al., 1999) . Cremediated recombination of this exon (exon 3 Dint*/ þ ) results in stabilization of b-catenin, immediate deregulation of b-catenin target genes, hyperproliferation of small intestinal crypt cells and development of adenomatous lesions (Harada et al., 1999) . Vil-CreER T2 activity was induced by tamoxifen injection in 6-week-old mice. After 3 weeks, macroscopical analysis revealed striking distension of the proximal small intestine and appearance of sheetlike neoplasia that was also evident by histological analysis (Figure 2a) . Activation of b-catenin was confirmed by immunohistochemistry revealing its nuclear translocation (data not shown). c-Jun was strongly expressed in controls, but not in double mutant mice, indicating that Vil-CreER T2 mediates efficient recombination of c-jun (Figure 2b) . However, the massive hyperproliferation of crypt-like cells observed upon activation of b-catenin was not altered in the absence of c-Jun, as determined by immunohistochemistry for Ki67 and phospho-Histone H3 (Figures 2c and d) . Moreover, the increased apoptosis observed upon activation of b-catenin was not altered in the absence of c-Jun (Figure 2e ). Activation of b-catenin also resulted in approximately 10-fold decrease in goblet cell numbers and abnormal Paneth cell positioning in the crypt, which was also not affected by deletion of c-Jun (data not shown).
In addition, activation of b-catenin resulted in nuclear accumulation of its target c-Myc irrespective of c-Jun expression (Figure 2f) . Expression of cd44, a c-Jun target gene in APC Min tumors (Nateri et al., 2005) , remained unchanged as assessed by quantitative PCR and immunohistochemistry (Figure 2g and data not shown). Importantly, similar morphological alterations were observed in APC Dint* mice, in which b-catenin was activated by conditional deletion of APC (Sansom et al., 2004; Andreu et al., 2005) . Again, no morphological differences were observed in mutant mice lacking c-Jun (APC Dint* c-jun Dint*
, Figure 2h ). In addition, the increased mortality observed in exon 3 Dint* and APC Dint* mice was apparently not reduced by additional deletion of c-jun (Figure 2i ). Both alleles of exon 3 were deleted in 
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Dint* mice, leading to a more rapid onset of the phenotype and thereby enabled a better comparison with APC Dint* mice. These findings indicate that c-Jun appears to be dispensable for the immediate intestinal phenotypes observed upon conditional activation of b-catenin.
Functions of c-Jun in mutagen-induced colonic neoplasia
Most genetic mouse models of b-catenin-dependent tumorigenesis such as APC Min mice or the conditional models used here are limited by the fact that tumors arise predominantly in the small intestine rather than in the colon. To study the functions of c-Jun during (h) Representative H&E staining of mice with the indicated genotypes 6 days after tamoxifen injection (nX3 mice per genotype). The size of the proliferating crypt compartment is indicated by black bars. (i) Kaplan-Meier plot demonstrating that survival upon deletion of APC (red, n ¼ 4) or activation of b-catenin (hatched black, n ¼ 3) is not prolonged upon additional deletion of c-jun (blue, n ¼ 8 and gray, n ¼ 7, respectively). Note that mice in which both alleles of exon 3 had been deleted were used for this experiment. Littermates not expressing Cre were used as controls (black, n ¼ 18).
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P Hasselblatt et al tumorigenesis in the colon proper, c-jun Dint mice were repeatedly injected with the mutagen azoxymethane (AOM) to induce premalignant aberrant crypt foci (ACF, Figures 3a and b) . ACF are frequently characterized by activating mutations of b-catenin (Takahashi and Wakabayashi, 2004) . All ACF in control mice strongly expressed c-Jun (Figure 3c) . However, the total number and size of ACF remained unchanged in c-jun Dint mice (Figure 3d ), suggesting that c-Jun is not required for ACF formation in the colon.
Functions of c-Jun in colitis-associated tumorigenesis c-Jun/AP-1 expression in various organs is strongly induced in response to proinflammatory signals such as cytokines or chemokines. To investigate the functions of c-Jun in colitis-associated tumors, c-jun Dint mice were treated with a single injection of AOM (12.5 mg/kg), followed by three cycles of dextran sulfate sodium (DSS) in drinking water to induce chronic colitis (Figure 4a ) (Tanaka et al., 2003; Greten et al., 2004) . AOM/DSSinduced tumors were predominantly localized in the distal colon and strongly expressed c-Jun (see below). However, tumor morphology, number, average size and relative size distribution were not altered in c-jun Dint mice (Figures 4b and c) . Accordingly, tumor cell proliferation and apoptosis remained unchanged in c-jun-deficient CAC (Figure 4d ). Similar findings were obtained using the Vil-CreER T2 line (c-jun Dint* ), in which deletion was induced 1 week before AOM injection (nX4 per genotype, data not shown).
Immunohistochemistry revealed nuclear translocation of b-catenin in all colitis-associated tumors, irrespective of the genotype (Figure 4e) . Importantly, none of the tumors in c-jun Dint mice expressed c-Jun as determined by immunohistochemistry, indicating that these tumors did not arise from cells that had escaped c-jun deletion (Figure 4f ). Besides c-jun, expression of junB was increased in colitis-associated tumors, whereas the fos genes were only weakly expressed (Figure 4g) . Importantly, expression of AP-1 genes other than c-jun was not altered in c-jun Dint tumors, suggesting that upregulation of other AP-1 members most likely did not compensate for the loss of c-jun (Figure 4g) .
To study the functions of c-Jun in myeloid cells, c-jun À/À or c-jun AA/AA mice, in which the N-terminal phosphorylation sites had been mutated (Figure 5a ). These findings indicate that c-Jun, although highly expressed in tumors, appears to be dispensable for colitis-associated tumorigenesis in mice.
Functions of other Jun and Fos proteins in colitis-associated tumorigenesis Our finding that expression of JunB was induced in CAC (Figure 4g ) raised the question whether other Jun proteins contribute to colitis-associated tumorigenesis. Therefore, colitis-associated tumors were induced in mice lacking junB in intestinal epithelium (junB Dint , Figure 5b ). In controls, immunohistochemistry revealed strong expression of JunB in both, tumor and infiltrating cells, which was absent in junB Dint tumor cells (Figure 5c ). However, tumor size and numbers were not altered in junB Dint mice (Figure 5d ). Unfortunately, we were unable to address the functions of JunB in myeloid cells, as junB Functions of AP-1 in intestinal tumorigenesis P Hasselblatt et al controls were highly resistant to AOM/DSS-induced tumorigenesis for as yet unknown reasons. In addition, no difference was detected in mice lacking junD (Figure 5d ), suggesting that single jun genes are dispensable for colitis-associated tumorigenesis. The increased expression of Fra-1 observed in human CRC and upon loss of APC in mice (Wang et al., 2002; Sansom et al., 2007) prompted us to examine the functions of Fra-1 and other Fos proteins in colitisassociated tumorigenesis. fra-1 RNA was hardly detectable in CAC (Figure 4g ) and tumor numbers and size were not altered in mice lacking fra-1 (fra-1 Figure 5e ). Moreover, tumor numbers and size were not affected by deletion of c-fos or fra-2 in either intestinal epithelium or myeloid cells (c-fos Dint , fra-2 Dint , c-fos Dmac and fra-2 Dmac , respectively, Figure 5e ). These findings suggest that these single AP-1 components appear to be dispensable for CAC.
Discussion
The transcription factor c-Jun/AP-1 has been proposed as a target of b-catenin signaling in human CRC (Mann et al., 1999) . In this study, we therefore examined the functions of c-Jun in various independent models of bcatenin-dependent cell proliferation and tumorigenesis. Under resting conditions, c-Jun was predominantly expressed in differentiated cells of the small intestinal villi, in which b-catenin activity is rather low (Clevers, 2006) , suggesting that c-Jun may be regulated in a bcatenin-independent manner in the healthy intestine. Expression of c-Jun was strongly induced in all models of b-catenin-dependent proliferation and tumorigenesis used here. Surprisingly, c-Jun did not contribute to the immediate phenotypes upon genetic inactivation of APC or activation of b-catenin. These findings are particularly interesting with regard to previous observations in APC Min mice, in which c-Jun and in particular phosphoc-Jun are required for tumor cell proliferation (Nateri et al., 2005) . The APC Min allele encodes a truncated protein leading to the small intestinal tumorigenesis upon loss of heterozygosity after several months of age (Taketo, 2006) . This is in contrast to the approach used in this study where the primary cellular and molecular consequences of b-catenin activation were investigated using conditional genetic approaches. The finding that c-Jun is not required in these settings suggests that c-Jun, although highly expressed, is not an immediate regulator of oncogenic b-catenin signaling, but may rather act during later stages of APC Min tumorigenesis. Interestingly, it was previously shown that cyclin D1, a canonical target gene of c-Jun/AP-1 (Shaulian and Karin, 2002) , is not required for the early phenotype upon conditional loss of APC, but significantly contributes to later stages of tumorigenesis in APC Functions of AP-1 in intestinal tumorigenesis P Hasselblatt et al mutations result in major differences in b-catenin pathway activation and tumor susceptibility (Clarke, 2006) , and it is therefore possible that a relatively weak b-catenin signal in APC Min mice might require activation of additional signaling pathways, such as JNK/c-Jun, to fully induce its transcriptional activity. In contrast, conditional activation of b-catenin in the models used here could result in a more robust signaling strength, which may not require additional activation of c-Jun. For instance, b-catenin regulates various robust intracellular pathways, as well as transcription factors such as c-Myc (Sansom et al., 2007) , which may be sufficient to induce cell proliferation in the absence of c-Jun. Future experiments using additional APC mutants will therefore be helpful to analyse the contribution of c-Jun to small intestinal tumorigenesis following inactivation n.6 Functions of AP-1 in intestinal tumorigenesis P Hasselblatt et al of APC. Tumorigenesis in APC Min mice is strongly influenced by various modifier genes and genetic background (Clarke, 2006) . The different phenotypes of c-jun deficiency in APC Min mice and the models used here may therefore also be affected by differences in genetic background, as a mixed 129/Sv Â C57BL/6 background was used here compared to C57BL/6 used by Nateri et al., 2005. Importantly, tumorigenesis in APC Min mice occurs predominantly in the small intestine rather than the colon. To study the functions of c-Jun and other AP-1 proteins in the process of tumorigenesis in the colon, we used models of mutagen-induced ACF formation and CAC, as AP-1 activity is commonly induced by inflammatory stimuli. The CAC model involves activation of b-catenin (Greten et al., 2004) , induces colorectal tumors which eventually progress to adenocarcinoma and mimics tumorigenesis associated with inflammatory bowel disease (Suzuki et al., 2004) . Although expression of c-Jun was again strongly induced, tumorigenesis was not altered in the absence of c-Jun either in intestinal epithelium or myeloid cells, suggesting that c-Jun is indeed dispensable for inflammation-associated tumorigenesis in the colon. The oncogenic functions of c-Jun in APC Min mice are dependent on N-terminal phosphorylation of c-Jun, for example, by the Jun kinase JNK (Nateri et al., 2005) , implicating JNK as potential oncogene in the intestine. In contrast, it was recently shown that JNK1 may also act as a tumor suppressor, as jnk1 À/À mice spontaneously develop intestinal neoplasia (Tong et al., 2007) . However, we did not observe any spontaneous tumors in jnk1 À/À mice, in which colitis-associated carcinogenesis was not altered.
Besides c-Jun, increased expression of JunB was observed in CAC, whereas expression of Fra-1 was rather weak. To obtain more comprehensive insights into the functions of distinct Jun (JunB, JunD) and Fos (c-Fos, Fra-1, Fra-2) proteins, colitis-associated tumors were induced in the respective knockout mice. Interestingly, major and significant differences in tumorigenesis were not observed in any of these mice, although our experiments do not exclude subtle and minor differences given the number of mice examined. These findings suggest that expression of single AP-1 proteins is either dispensable in CAC or that several AP-1 components might have to be simultaneously targeted to impair tumorigenesis. In conclusion, our findings indicate that the functional relevance of c-Jun expression after conditional activation of b-catenin in the small intestine and in colonic tumorigenesis may be rather limited. Moreover, our data suggest that inhibition of c-Jun or other single AP-1 proteins is most likely not a promising approach to treat CAC.
Materials and methods
Animals
Mice with conditional alleles for c-jun, junB, c-fos, fra-2, b-catenin(exon 3) and APC (Shibata et al., 1997; Harada et al., 1999; Behrens et al., 2002; Fleischmann et al., 2003; Kenner et al., 2004; Eferl et al., 2007) were crossed with transgenic mice expressing Vil-Cre, Vil-CreER T2 (el Marjou et al., 2004) or LysM-Cre (Clausen et al., 1999) . Either c-jun f/f , c-jun f/D or Vil-Cre c-jun f/ þ littermates were used as controls for c-jun Dint mice. Jnk1
À/À
, junD À/À and fra-1 D/D (deletion in the entire embryo) mice have been described (Thepot et al., 2000; Sabapathy et al., 2001; Eferl et al., 2004) . Mice were kept on a mixed genetic background (C57Bl/6 Â 129/Sv) and littermates were used as controls.
Mouse experiments
To induce recombination by Vil-CreER T2 , mice 6-8 weeks of age were injected daily intraperitoneally with 1 mg tamoxifen (Sigma, Vienna, Austria) for 5 days and killed at the indicated time points. To induce colitis-associated tumors, 6-week-old mice were injected with azoxymethane (12.5 mg/kg intraperitoneally, Wako, Neuss, Germany), followed by three cycles of DSS (2.5% in drinking water, MP Biomedicals, Illkirch, France) as described (Greten et al., 2004) . ACF were induced by weekly injections of AOM (12.5 mg/kg) for 6 weeks and mice were killed 4 weeks thereafter. All animal experiments were performed in accordance with local and institutional regulations.
Histology and immunohistochemistry
Intestines were fixed in 4% neutral buffered formaldehyde at 4 1C and embedded in paraffin. Tumors were quantified on serial hematoxylin and eosin stained sections using ImageJ software (NIH, Bethesda, MD, USA). Immunohistochemistry was performed using antibodies for c-Jun (Cell Signaling, Danvers, MA, USA), JunB (N-17, Santa Cruz, Heidelberg, Germany), b-catenin (BD Transduction labs, Schwechat, Austria), Ki67 (Novocastra, Newcastle, UK), phosphoHistone H3 Ser10 (Upstate, Vienna, Austria), c-Myc (N-262, Santa Cruz), CD44 (BD) and cleaved caspase 3 (Cell Signaling).
RNase protection assay and Southern blot analysis
For RNA analysis, all tumors of a single mouse were pooled and total RNA was isolated using Trizol (Invitrogen, Lofer, Austria). RNase protection assay was performed using the Riboquant multiprobe RNase protection assay systems mFos/Jun (BD). Quantitative PCR was performed with SYBR green on an Opticon 2 Monitor Fluorescence Thermocycler (MJ Research, Waltham, MA, USA). Southern blot analysis of c-jun has been described (Behrens et al., 2002) .
Statistical analysis
Data in bar graphs represent mean±s.d., statistical analysis was performed using non-directional two-tailed student's t-test.
